How AuraWell’s PEMF Technology Delivered a 27% Average Reduction in Prostate Size in a Clinical Case Study
Benign Prostatic Hyperplasia (BPH) affects millions of men worldwide, often leading to discomfort, disrupted sleep, urinary complications, and a reduced quality of life. Traditional treatment options can include medications, invasive procedures, or surgery—solutions many patients hope to avoid.
AuraWell set out to explore a different path: a non-invasive, drug-free approach using clinical-strength Pulsed Electromagnetic Field (PEMF) technology.
The results were significant.
A recently published clinical case study demonstrated an average 27% reduction in prostate size over 30 days using AuraWell’s Nova HD PEMF devices, with participants also reporting reduced discomfort and improved urinary flow—all without adverse effects.
The Challenge
BPH is one of the most common urological conditions affecting aging men, with prevalence increasing dramatically after age 50. Symptoms can include:
- Frequent nighttime urination
- Reduced urinary flow
- Pelvic discomfort
- Sleep disruption
- Ongoing inflammation
Many patients seek alternatives to medications and surgery due to side effects, recovery concerns, or inconsistent long-term outcomes.
AuraWell believed there was another option worth investigating.
The Research
The clinical case study was conducted by:
- Dr. Roberta Kline
- Lennard Goetze, PhD
- Robert Bard, MD
- Paul Dreschnak, MD
The research team evaluated three men diagnosed with benign prostatic hyperplasia (BPH) using AuraWell’s Nova HD PEMF technology over a structured treatment protocol.
The study was published in the Journal of Regenerative Medicine and Biology Research and was conducted independently by the research team after AuraWell provided device access and operational guidance.
The Solution: Clinical-Strength Portable PEMF
AuraWell’s Nova HD devices use professional-grade PEMF technology designed to support circulation, cellular oxygenation, and recovery processes throughout the body.
The treatment protocol focused on:
- Moderate, sustainable dosing
- Comfortable session structures
- Consistent daily application
- Non-invasive treatment delivery
According to AuraWell CEO, Alane Paulley, the technology was designed to support the body’s natural recovery response by improving blood flow and reducing inflammation.
The Results
Average 27% Reduction in Prostate Size
After 30 days of PEMF sessions, participants experienced:
- An average 27% decrease in prostate size
- Improved urinary flow
- Reduced discomfort
- Early symptom changes often within the first week
- No reported adverse effects
The findings suggest that clinical-strength PEMF may offer a promising supportive approach for men seeking non-invasive wellness options.
Why This Matters
The significance of the study goes beyond prostate health alone.
The research reinforces a growing interest in how PEMF technology may support:
- Circulation and vascular function
- Inflammation management
- Recovery and cellular performance
- Everyday wellness and quality of life
It also represents an important milestone in AuraWell’s broader mission: bringing professional-grade PEMF technology into a portable, approachable format designed for real life.
A New Direction for At-Home Recovery
AuraWell continues to advance clinical-strength PEMF technology with a focus on accessibility, ease of use, and FDA-cleared innovation for home recovery applications. Recent industry coverage has highlighted AuraWell’s role in bringing professional-grade PEMF into the consumer wellness space.
For users seeking a non-invasive, drug-free recovery experience, AuraWell represents a new generation of portable PEMF technology built for everyday use.
Explore AuraWell
Discover how AuraWell is bringing clinical-strength PEMF technology into homes, recovery routines, and wellness practices nationwide.
Visit AuraWell.com to learn more.